FLT3 and acute myeloid leukemia: Therefore, all those benzimidazole-based scaffolds had to be fully examined for their physicochemical properties, tolerability, cell cycle arrest, and apoptosis induction capabilities to facilitate the development of more potent and selective FLT3 inhibitors against various FLT3 AML cells.